NASP Response to PCMA Comments Regarding DIR Fees

,

Published by Specialty Pharmacy Times:

“On behalf of NASP, I am writing to correct some misperceptions noted in the Specialty Pharmacy Times article citing the views of PCMA President and CEO Mark Merritt on Direct and Indirect Remuneration Fees. It is inaccurate to state that DIR Fees “don’t harm the health industry in any way; They only help it.” Unfortunately DIR Fees do harm the health industry, particularly as it relates to the negative impact on specialty pharmacy providers.”

Read the Entire Article

Pharmacists Survey: Prescription Drug Costs Skewed by Fees on Pharmacies, Patients

,

Published by The National Community Pharmacists Association:

“ALEXANDRIA, Va. (June 28, 2016) Most independent community pharmacists consistently encounter misleading and confusing fees imposed by prescription drug middlemen that negatively impact both pharmacies and patients and distort medication costs and reimbursement rates, according to a recent survey of 640 pharmacists conducted by the National Community Pharmacists Association (NCPA).”

Read the Entire Article